Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 275

1.

Growth and maturity status of elite British junior tennis players.

Myburgh GK, Cumming SP, Coelho E Silva M, Cooke K, Malina RM.

J Sports Sci. 2016 Mar 1:1-8. [Epub ahead of print]

PMID:
26930031
2.

OUTCOMES AND PROGNOSTIC FACTORS ASSOCIATED WITH CANINE SINONASAL TUMORS TREATED WITH CURATIVE INTENT CONE-BASED STEREOTACTIC RADIOSURGERY (1999-2013).

Kubicek L, Milner R, An Q, Kow K, Chang M, Cooke K, Fox L, Farese J, Bacon N, Lurie D.

Vet Radiol Ultrasound. 2016 May;57(3):331-40. doi: 10.1111/vru.12349. Epub 2016 Feb 15.

PMID:
26880676
3.

Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders.

Klein OR, Chen AR, Gamper C, Loeb D, Zambidis E, Llosa N, Huo J, Dezern AE, Steppan D, Robey N, Holuba MJ, Cooke KR, Symons HJ.

Biol Blood Marrow Transplant. 2016 May;22(5):895-901. doi: 10.1016/j.bbmt.2016.02.001. Epub 2016 Feb 6.

PMID:
26860634
4.

Automatic Stem Cell Detection in Microscopic Whole Mouse Cryo-Imaging.

Wuttisarnwattana P, Gargesha M, Van't Hof W, Cooke KR, Wilson DL.

IEEE Trans Med Imaging. 2016 Mar;35(3):819-29. doi: 10.1109/TMI.2015.2497285. Epub 2015 Nov 2.

PMID:
26552080
5.

Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors.

Wurz RP, Pettus LH, Ashton K, Brown J, Chen JJ, Herberich B, Hong FT, Hu-Harrington E, Nguyen T, St Jean DJ Jr, Tadesse S, Bauer D, Kubryk M, Zhan J, Cooke K, Mitchell P, Andrews KL, Hsieh F, Hickman D, Kalyanaraman N, Wu T, Reid DL, Lobenhofer EK, Andrews DA, Everds N, Guzman R, Parsons AT, Hedley SJ, Tedrow J, Thiel OR, Potter M, Radinsky R, Beltran PJ, Tasker AS.

ACS Med Chem Lett. 2015 Jul 27;6(9):987-92. doi: 10.1021/acsmedchemlett.5b00193. eCollection 2015 Sep 10.

PMID:
26396685
6.

Exercise as potential countermeasure for the effects of 70 days of bed rest on cognitive and sensorimotor performance.

Koppelmans V, Mulavara AP, Yuan P, Cassady KE, Cooke KA, Wood SJ, Reuter-Lorenz PA, De Dios YE, Stepanyan V, Szecsy DL, Gadd NE, Kofman I, Scott JM, Downs ME, Bloomberg JJ, Ploutz-Snyder L, Seidler RD.

Front Syst Neurosci. 2015 Sep 3;9:121. doi: 10.3389/fnsys.2015.00121. eCollection 2015.

7.

Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.

Jacoby E, Chen A, Loeb DM, Gamper CJ, Zambidis E, Llosa NJ, Huo J, Cooke KR, Jones R, Fuchs E, Luznik L, Symons HJ.

Biol Blood Marrow Transplant. 2016 Jan;22(1):112-8. doi: 10.1016/j.bbmt.2015.08.034. Epub 2015 Sep 4.

PMID:
26343947
8.

Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia.

Abu-Arja RF, Chernin LR, Abusin G, Auletta J, Cabral L, Egler R, Ochs HD, Torgerson TR, Lopez-Guisa J, Hostoffer RW, Tcheurekdjian H, Cooke KR.

Pediatr Blood Cancer. 2015 Sep;62(9):1674-6. doi: 10.1002/pbc.25554. Epub 2015 Apr 20.

PMID:
25900577
9.

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.

Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87. doi: 10.1016/j.bbmt.2015.04.004. Epub 2015 Apr 7.

PMID:
25862591
10.

The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.

Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KR, Pasquini MC, McCarthy PL.

Biol Blood Marrow Transplant. 2015 Jul;21(7):1251-7. doi: 10.1016/j.bbmt.2015.03.017. Epub 2015 Mar 31.

PMID:
25840335
11.

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.

Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OT, Pasquini MC, Schriber JR, Cooke KR.

Leukemia. 2015 Aug;29(8):1754-62. doi: 10.1038/leu.2015.75. Epub 2015 Mar 16.

12.

Dynamic exophthalmos and lateral strabismus in a dog caused by masticatory muscle myositis.

Czerwinski SL, Plummer CE, Greenberg SM, Craft WF, Conway JA, Perez ML, Cooke KL, Winter MD.

Vet Ophthalmol. 2015 Nov;18(6):515-20. doi: 10.1111/vop.12260. Epub 2015 Feb 26.

PMID:
25728848
13.

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

Chen YB, Lane AA, Logan BR, Zhu X, Akpek G, Aljurf MD, Artz AS, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson RF, Saber W, McCarthy PL, Pasquini MC.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1046-53. doi: 10.1016/j.bbmt.2015.02.005. Epub 2015 Feb 14.

PMID:
25687795
14.

Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation.

Varelias A, Gartlan KH, Kreijveld E, Olver SD, Lor M, Kuns RD, Lineburg KE, Teal BE, Raffelt NC, Cheong M, Alexander KA, Koyama M, Markey KA, Sturgeon E, Leach J, Reddy P, Kennedy GA, Yanik GA, Blazar BR, Tey SK, Clouston AD, MacDonald KP, Cooke KR, Hill GR.

Blood. 2015 Apr 9;125(15):2435-44. doi: 10.1182/blood-2014-07-590232. Epub 2015 Feb 11.

15.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

Paczesny S, Hakim FT, Pidala J, Cooke KR, Lathrop J, Griffith LM, Hansen J, Jagasia M, Miklos D, Pavletic S, Parkman R, Russek-Cohen E, Flowers ME, Lee S, Martin P, Vogelsang G, Walton M, Schultz KR.

Biol Blood Marrow Transplant. 2015 May;21(5):780-92. doi: 10.1016/j.bbmt.2015.01.003. Epub 2015 Jan 30.

16.

Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.

Auletta JJ, Eid SK, Wuttisarnwattana P, Silva I, Metheny L, Keller MD, Guardia-Wolff R, Liu C, Wang F, Bowen T, Lee Z, Solchaga LA, Ganguly S, Tyler M, Wilson DL, Cooke KR.

Stem Cells. 2015 Feb;33(2):601-14. doi: 10.1002/stem.1867.

17.

TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).

Yanik GA, Grupp SA, Pulsipher MA, Levine JE, Schultz KR, Wall DA, Langholz B, Dvorak CC, Alangaden K, Goyal RK, White ES, Collura JM, Skeens MA, Eid S, Pierce EM, Cooke KR.

Biol Blood Marrow Transplant. 2015 Jan;21(1):67-73. doi: 10.1016/j.bbmt.2014.09.019. Epub 2014 Sep 28.

18.

Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.

Bhaskaran S, Abu-Arja RF, Abusin G, Cabral L, Nagle K, Ahuja S, Egler R, Cooke KR, Lazarus HM.

Bone Marrow Transplant. 2014 Dec;49(12):1550-1. doi: 10.1038/bmt.2014.205. Epub 2014 Sep 22. No abstract available.

PMID:
25243621
19.

Intravesical instillation of amikacin for treatment of a lower urinary tract infection caused by Pseudomonas aeruginosa in a dog.

Torres AR, Cooke K.

J Am Vet Med Assoc. 2014 Oct 1;245(7):809-11. doi: 10.2460/javma.245.7.809.

PMID:
25229532
20.

Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.

Paczesny S, Duncan C, Jacobsohn D, Krance R, Leung K, Carpenter P, Bollard C, Renbarger J, Cooke K.

Proteomics Clin Appl. 2014 Dec;8(11-12):837-50. doi: 10.1002/prca.201400033. Epub 2014 Oct 30. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk